1. The Research Question
Does self monitoring of blood glucose (SMBG) in patients with non-insulin treated type 2 diabetes improve glycemia or quality of life?

2. What the Researchers Did
Pragmatic RCT of 3 SMBG testing approaches over 1 year in 450 patients with non-insulin treated type 2 diabetes
Group 1: No SMBG testing
Group 2: Once daily SMBG testing with standard feedback
Glucose values reported on monitor
Group 3: Once daily SMBG testing with enhanced feedback
Glucose values reported on monitor plus a tailored feedback message delivered to the patient through the monitor

3. What the Researchers Found
Over the course of 1 year, there were no clinically or statistically significant differences in glycemic control or quality of life between patients with non insulin treated diabetes who perform SMBG compared to those who do not perform SMBG
The addition of tailored feedback provided through messaging via a glucometer did not provide any advantage in glycemic control

4. What This Means for Clinical Practice
Glucose monitoring in patients with non-insulin treated type 2 diabetes should not be routine.
Enhanced glucose monitoring, at least in the pragmatic real world setting offered no additional health benefits